Philip Morris International Inc. Earnings Recaps
Q1 2026
Apr 22, 2026
PMI delivered a resilient Q1 with 9% revenue growth driven by strong smoke-free performance, pricing power, and cost management, despite challenging industry volume trends.
Key takeaways
- International smoke-free business achieved nearly 12% volume growth, with IQOS and ZYN contributing significantly to high single-digit organic top-line expansion.
- Adjusted EPS rose 16% to $1.96, supported by favorable currency effects and solid operational execution.
- Total revenues surpassed $10 billion, up 9%, with organic growth of 2.7%, outperforming flat expectations amid U.S. and combustibles headwinds.
- Smoke-free shipments up 9.1%, with notable growth in HTU and e-vapor offsetting oral smoke-free declines; smoke-free volume increased 11%.
- Cigarette volumes declined more than expected at the high end of estimates, influenced by industry declines, excise taxes, and illicit consumption, with expectations of moderation over the coming quarters.
Q3 2025
Oct 21, 2025
Philip Morris International reported robust Q3 results, achieving record smoke-free gross profit exceeding $3 billion and a 17% increase in adjusted diluted EPS to $2.24, driven by strong growth in its global smoke-free business.
Key takeaways
- Smoke-free product volume growth accelerated to 16.6% in Q3, significantly outpacing the global market.
- Adjusted operating income rose 7.5% organically to $4.7 billion, with an adjusted operating income margin expansion of 120 basis points.
- The launch of IQOS in Taiwan and continued expansion into 100 markets underscores a strong commitment to geographic growth.
- Combustibles demonstrated resilience with better-than-expected volumes, particularly in Turkey and Egypt, contributing positively to overall financial performance.
- Year-to-date organic net revenue growth reached 7.5%, aligning with mid-term growth targets despite the temporary impact from Indonesia.